<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
LSX-Blog.png

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

CMR Surgical prepares for commercialisation on the...

Key findings: In June 2018, surgical robotics company CMR Surgical raised $...

Read More

Endomag secures £8m Series C for scale up

Key learnings: UK and US-based Endomag raised £8 million through its Series...

Read More

PharmaKrysto kickstarts cystinuria drug developmen...

Key learnings: PharmaKrysto has signed a licensing deal with Rutgers Univer...

Read More

Avacta looks to deals to leverage Affimer platform...

Key learnings: UK-based Avacta Group has developed Affimer® technology, an ...

Read More

Novoheart expands global presence to support comme...

Key learnings: Novoheart has developed human bioengineered heart constructs...

Read More

PhoreMost raises £11m Series A round to progress t...

Key learnings: PhoreMost completed its Series A round in May 2018, with a t...

Read More

Aparito applies remote patient monitoring tech to ...

Key learnings: Wales-based digital health company Aparito utilises wearable...

Read More

Cognetivity’s AI-driven cognitive test seeks to ad...

Key learnings: Cognetivity Neurosciences was named joint winner in the Inno...

Read More

Grace cooling device marries design and automation...

Key learnings: Cooling device, Grace, won the Peri-Menopause Challenge cate...

Read More

NMD Pharma to advance neuromuscular disorder thera...

Key learnings:

Read More

£29m Series B spurs Enterprise Therapeutics’ muco-...

Key learnings:

Read More

Zilico’s diagnostic device moves towards Chinese a...

Key learnings: UK-based Zilico has entered into a strategic deal with MaxHe...

Read More

Add Your Response